Highlights of the annual meeting of the European Association of Nuclear Medicine: Glasgow 1997. The Flowering of Science and Art of Nuclear Medicine in Europe

European Journal of Nuclear Medicine

Volumn 24, Issue 12, 1997, Pages 1527-1540

  Carrió, Ignasi ^a  

^a Sant Pau University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EUROPE; NUCLEAR MEDICINE; REVIEW; UNITED KINGDOM;

EUROPE; HUMANS; NUCLEAR MEDICINE; SOCIETIES, MEDICAL;

EID: 0031450643     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050184     Document Type: Review

References (87)

1. Severi S, Leonardi E, Lorenzi E, Bonanzini M, Brancato B, Romano M, Camerani M. The 99mTc MIBI breast cancer concentration in mammoscintigraphy: relation with tumour cellularity and mitotic index. Eur J Nucl Med 1997;8:905.
2. Scopinaro F, De Vincentis G, Pani R, Pellegrini R, Soluri A, Ierardi M, Danieli R, Tiberio N, Ballesio L. Single photon high resolution emission scintimammography: preliminary clinical results. Eur J Nucl Med 1997;8:1048.
3. Tiling R, Linke H, Sommer M, Pechmann M, Gebauer K, Tatsch K, Hahn K. Scintimammography with sestamibi for detection of breast carcinoma: diagnostic accuracy of planar, SPECT, and combined data evaluation. Eur J Nucl Med 1997;8:916.
4. François D, Hermans J, Bodart F, Merlo P, Boudart C, Boudart J, Beauduin M. Visual and quantitative analysis of 99mTc MIBI uptake in malignant and benign breast lesions. Eur J Nucl Med 1997;8:917.
5. Ierardi M, Schillaci O, Scopinaro F, Danieli R, Tiberio N, DiLuzio E. 99mTc-MIBI scan in the recurrence of cancer after breast cancer surgery. Eur J Nucl Med 1997;8:1047.
6. Azaloux H, Moretti JL, Kouyoumgjian JC, Boisseron D. Sestamibi Tc99m scintigraphy in breast cancer compared to prognostic factors. Eur J Nucl Med 1997;8:916.
7. Crippa F, Agresti R, Greco M, Pascali C, Bogni A, Chiesa C, DeSantis V, Delledone V, Salvadori B, Leutner M, Decise D, Bombardieri E. FDG-PET in the presurgical staging of the axilla in breast cancer. Eur J Nucl Med 1997;8:882.
8. Paganelli G, DeCicco C, Luini A, Cassano E, Pizzamiglio M, Fiorenza M, Galimberti V, Zurrida S, Veronesi V. Radioguided surgery in non-palpable breast lesions. Eur J Nucl Med 1997;8:893.
9. Palmedo H, Biersack J, Lastoria S, Maublant J, Prats E, Bourgeois P, Rigo P, Hilson A, Bischof-Delaloye A, Stegner H. Value of Tc99m MIBI in the diagnosis of primary breast cancer: results of the prospective European Multicenter trial. Eur J Nucl Med 1997;8:992.
10. Danieli R, Schillaci O, Scopinaro F, Angelleti S, Tavolaro R, Polettini E, Cannas P, Gualdi G, Dellefave G, Centicolella A. Value of somatostatin receptor scintigraphy in the detection of liver metastasis in gastroenteropancreatic endocrine tumors. Eur J Nucl Med 1997;8:1049.
11. Le Stanc E, Flobert C, Bonnin F, Stievenart JL, Ruzsniewski P, Bok B. Systematic histology and somatostatin receptor scintigraphy sensitivity in gastro-entero-pancreatic tumors. Eur J Nucl Med 1997;8:875.
12. Adams S, Baum RP, Scumm-Drager PM, Usadel K, Hör G. Imaging of neuroendocrine tumors with 18F-FDG PET, 111In-somatostatin receptor and 99mTc-V-DMSA scintigraphy. Eur J Nucl Med 1997;8:925.
13. Virgolini I, Szilvasi I, Smith-Jones P, Angelberger P, Kurtaran A. "Mauritius": animal and human biodistribution and tumor localization. Eur J Nucl Med 1997;8:874.
14. Eigtved A, Larsen P, Jensen M, Foder B, Holm S, Hansen A, Iversen P, Friberg L. 16Beta-F18-fluoro-51Ifa-dihydro-testosterone as an androgen receptor ligand for PET studies of the prostate. Eur J Nucl Med 1997;8:914.
15. Nuutinen JM, Leskinen S, Lindholm P, Södestrom K, Nagrem K. Ruotsalainen U, Salminen E, Minn H. C-11 methionine PET in prediction of malignancy grade and survival in untreated lymphomas. Eur Nucl Med 1997;8:861.
16. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schäfers M, Palkovic S, Matheja P, Brandau W, Wassman H, Schober O. Diagnosis of recurrent glioma with SPECT and I123-methyltyrosine. Eur J Nucl Med 1997;8:859.
17. Nakamura K, Fujii H, Kubo A, Satake S, Takami H, Sugawara I. In vivo evaluation of P-glycoprotein by I125-labelled MRK-16 monoclonal antibody or Tc-99m MIBI. Eur J Nucl Med 1997;8:869.
18. Tabuenca MJ, Vargas JA, Peiró V, Novoa N, Salas C, Alonso M, Ortiz-Berrocal J. Use of 99m-tetrofosmin in patients with solitary pulmonary nodule: correlation with multidrug resistance. Eur J Nucl Med 1997;8:906.
19. Vuillez JP, Moro D, Brichon PY, Rouvier E, Brambilla E, Barbet J, Brambilla C. Two step immunoscintigraphy using an anti-CEA/anti-DTPA bispecific antibody and In-111 labeled di-DTPA for mediastinal staging of non small cell lung carcinoma. Eur J Nucl Med 1997;8:864.
20. Sumiya H, Taki J, Tonami N, Asada N, Tsuchiya H, Tomita K. Thallium-201 scintigraphy in prediction of response to chemotherapy in bone and soft tissue tumors. Eur J Nucl Med 1997;8:917.
21. Lomeña F, Vidal-Sicart S, Cruceta A, Pavía J, Miró J, Mañé S, García F, Herranz R, Ribera E, Graus F. Predictive value of 201-thallium SPECT in the diagnosis of primary brain lymphoma in AIDS patients. Eur J Nucl Med 1997;8:859.
22. Dresel S, Weiss M, Heckmann M, Rosmüller B, Konz B, Tatsch K, Hahn K. Pre-and intraoperative detection of the sentinel lymph node in malignant melanoma: combined lymphoscintigraphy and gamma probe guidance. Eur J Nucl Med 1997;8:893.
23. Colarinha P, Bivar J, Salgado L, Oliveira P, Faria J, Sousa J, Almeida J, Vieira MR. Lymphoscintigraphy in early stage cutaneous melanoma: selective lymphadenectomy. Eur J Nucl Med 1997;8:892.
24. DeCicco C, Sideri M, Bartolemi M, Maggioni A, Colombo N, Leonardi L, Paganelli G. Lymphoscintigraphy and radioguided biopsy of the sentinel node in patients with vulvar cancer. Eur J Nucl Med 1997;8:892.
25. Popescu DG, Fauchet M, Askienazy S, Sauret V. Mini beta probe with scintillating fibre detecting millimetres tumors. Eur J Nucl Med 1997;8:888.
26. Mainolfi C, Maurea S, Alaia P, Varrella P, Imparato C, Roma R, Abate L, Bazzicalupo L, Salvatore M. Follow-up evaluation of patients with lymphoma using F-18 FDG PET: comparison with conventional imaging techniques. Eur J Nucl Med 1997;8:993.
27. Mainolfi C, Maurea S, Varrella C, Alaia C, Imparato C, Lacagnina A, DeRosa V, Ziviello M, Bazzicalupo L, Salvatore M. Characterization of solitary pulmonary nodules and staging of lung cancer using F-18 FDG PET: comparison with CT. Eur J Nucl Med 1997;8:994.
28. Garcia Velloso MJ, Gámez C, Alcalde J, Azinovic I, Paloma V, Arbizu J, Richter J. Positron emission tomography with 18F-FDG in head and neck tumors. Eur J Nucl Med 1997;8:1027.
29. Adams S, Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities in lymphonodal staging of head and neck cancer. Eur J Nucl Med 1997;8:872.
30. Lonneux M, Bausart R, Detry F, Jamar F, Pawels S. Isolated CEA elevation in colorectal cancer follow-up: impact of 18F-fluorodeoxyglucose positron emission tomography. Eur J Nucl Med 1997;8:882.
31. Dimitrakopoulou-Strauss A, Strauss L, Schlag P, Hohenberger P, Oberdorfer F, Kontaxakis G, van Kaick G. PET studies with O-15 water and F-18-fluorouracil: comparison of systemic and regional administration in liver metastases. Eur J Nucl Med 1997;8:861.
32. Dimitrakopoulou-Strauss A, Strauss L, Gutzler F, Oberdofer F, Irngartinger G, Kontaxakis G, van Kaik G. Positron emission tomography with C-11-ethanol and F-18-deoxyglucose in hepatocellular carcinomas for therapy management. Eur J Nucl Med 1997;8:923.
33. Young H, Deenamode M, Glass D, Swirsky D, Peters AM. Whole body PET imaging of erythropoiesis with 52Fe-transferrin and a 3D PET scanner, the ECAT ART. Eur J Nucl Med 1997;8:930.
34. Sandler MP, Delbecke D, Patton JA, Martin W, Vithalani R, Balan A. Comparison of FDG PET and coincidence ECT imaging using a dual head scintillation camera in patients with suspected malignancies. Eur J Nucl Med 1997;8:860.
35. Loc'h C, Bottlaender M, Kassiou M, Musachio J, London E, Dannals R, Maziere B. Evaluation of a Br-76 analog of epibatidine for PET imaging of nicotinic acetylcholine receptors. Eur J Nucl Med 1997;8:913.
36. Almeida P, Ribeiro MJ, Bottlander M, de Dreuille O, Loc'h C, Maziere B, Bendriem B. Quantitative kinetics of 123I-epidepride in baboon brain measured with attenuation corrected SPECT. Eur J Nucl Med 1997;8:1036.
37. Kuikka JT, Tihonen J, Bergstrom K, Akerman K, Rasanen P. Striatal SPET imaging with I123-epidepride and I123-beta CIT in healthy males. Eur J Nucl Med 1997;8:922.
38. Kuikka JT, Tihonen J, Karhu KA, Bergstrom K, Rasanen P, Eronen M. Fractal analysis of striatal dopamine transporter density in alcoholics. Eur J Nucl Med 1997;8:935.
39. Halldin C, Langer O, Lundkvist C, Sandell J, Olsson H, Swahn C, Hall H, Karlsson P, Loc'h C, Bottlaender M, Bendriem D, Maziere B, Farde L. Extrastriatal dopumine D2 receptors in the monkey and human brain visualized by C11 epidepride using PET and autoradiography. Eur J Nucl Med 1997;8:1057.
40. Tatsch K, Borasio GD, Linke R, Dresel S, Mozley P, Scherer J, Fieber R, Hahn K. Amyotrophic lateral sclerosis: evidence for dopaminergic deficit assessed with IPT SPET. Eur J Nucl Med 1997;8:923.
41. Kawabata K, Tachibana H, Sugita M, Fukuchi M. Comparative SPECT study with I123 iomazanil and I123 iodoamphetamine in Parkinson's disease. Eur J Nucl Med 1997;8:1043.
42. Kuwert T, Matheja P, Stodieck S, Diehl B, Wolf K, Schafers M, Schafers K, Lerch H, Ringelstein E, Schober O. Frequency of GABA receptor density reduction in newly diagnosed and chronic complex-partial seizures. Eur J Nucl Med 1997;8:934.
43. Setoain FJ, Lomeña F, Arroyo S, Pavia J, Catafau A, Rumia J, Vidal-Sicart S, Setoain J. Ictal/postictal 99mTc-HMPAO brain SPECT in epilepsy. Eur J Nucl Med 1997;8:934.
44. Darcourt J, Migneco O, Mahagne MH, Fournier J, Bertrand F, Bussiere F. Early 99mTc-ECD brain SPECT and neurological recovery after stroke. Eur J Nucl Med 1997;8:916.
45. Barthel H, Hesse H, Berrouschot J, Schneider D, Knapp W. Differentiation between reversible cerebral ischemia and acute stroke using Tc99m-ECD SPECT. Eur J Nucl Med 1997;8:916.
46. Stevens H, Jansen M, Lemmerling M, de Jong B, Willemsen A, DeReuk J, Korf J. Co55-PET in cerebral ischemia in relation to bloodflow, oxygen metabolism and Gd-MRI. Eur J Nucl Med 1997;8:915.
47. Colamussi P, Cittadini C, Giganti M, Govoni M, Trotta F, Ricci R, Barbarella G, Piffanelli A. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of cerebral lupus. Eur J Nucl Med 1997;8:1046.
48. Benti R, Turconi AC, Felisari G, Marotta G, Canzi C, Casati R, Sdraia C, Longari V, Gasparini M, Castellani M, Bresolin N, Gerundini P. Tc99m-ECD brain SPET and neuropsychological profile in mitochondrial encephalomyopathies without cognitive deficit. Eur J Nucl Med 1997;8:870.
49. Catafau A, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Berná LI, Marí C, Casas M, Carrió I. Regional cerebral blood flow changes induced by naltrexone challenge in alcohol dependent patients. Eur J Nucl Med 1997;8:891.
50. Schreckenberger M, Gouzoulis E, Sabri O, Arning Ch, Kaiser H, Wagenknecht G, Sass H, Buell U. Effects of "ecstasy" on cerebral glucose metabolism: a PET activation study during experimental psychosis. Eur J Nucl Med 1997;8:978.
51. Okudan B, Gokçora N, Ergun U, Karabacak N, Atasever T, Gucuyener K, Oktem F. The evaluation baseline and linguistic activation brain SPECT in dyslexia. Eur J Nucl Med 1997;8:945.
52. Tutus A, Kibar M, Sofuoglu S, Gonul AS. A Tc99m HMPAO brain SPECT study in adolescent patients with major depressive disorder. Eur J Nucl Med 1997;8:979.
53. Ahonen A, Dahlstrom, Moilanen P, Torniainen P, Heikkila J. Brain serotonin transporters in depressive children. Eur J Nucl Med 1997;8:945.
54. Gordon I, Lask B, Bryant-Waugh R, Christie D, Timimi S. A possible biological substrate underlying anorexia nervosa. Eur J Nucl Med 1997;8:946.
55. Cuocolo A, Pace P, Sullo E, Nicolai E, Caldei S, Acampa W, Varrone A, Salvatore M. Comparison between technetium-99m sestamibi and tetrofosmin tomography in the diagnosis and localization of coronary artery disease. Eur J Nucl Med 1997;8:905.
56. Cuoccolo A, Nicolai M, Petretta M, Pace L, Cardei S, Varrone A, Trimarco B, Salvatore M. Coronary revascularization improves survival and left ventricular function in patients with chronic coronary artery disease and dysfunctional but viable myocardium at thallium-201 imaging. Eur J Nucl Med 1997;8:893.
57. Lucignani G, Landoni C, Paolini G, Galli L, Zuccani M, Di Credico G, Rossetti C, Pelenghi S, Grossi A, Striano G, Fazio F. Prognostic assessment by PET-FDG of patients with CAD and severe LVD prior to CABG. Eur J Nucl Med 1997;8:925.
58. Athanasoulis T, Nanas J, Hatzifotiadis D, Kontoyannis D, Alexopoulos G, Kostamis P. Early and late Tc99m-tetrofosmin images in patients with recent myocardial infarction. Comparison with thallium rest-redistribution images. Eur J Nucl Med 1997;8:950.
59. Faraggi M, Karila-Cohen D, Lebtahi R, Czitrom D, Sarda L, Brochet E, Assayag P, Doumit D, Steg P, Le Guludec D. Myocardial contrast echocardiography and early rest thallium reverse redistribution demonstrate successful microvascular reperfusion in patients with acute myocardial infarction and patent infarct-related artery. Eur J Nucl Med 1997;8:894.
60. Richter W, Beckmann S, Aurisch R, Schartl M, Munz DL. Myocardial fatty acid metabolism is impaired in segments with reverse redistribution. Eur J Nucl Med 1997;8:937.
61. Kawai Y, Tsukamoto E, Abe H, Kishino K, Kohya T, Tamaki N. Can BMIPP identify areas at risk in patients with myocardial infarction? Eur J Nucl Med 1997;8:997.
62. Bontemps L, Nazzi M, Gabain M, Sayegh Y, Dayoub G, Jegaden O, Itti R. Quantification of perfusion, viability and contraction in patients with impaired left ventricular function, before and after surgical revascularization. Eur J Nucl Med 1997;8:950.
63. Weise R, Baller D, Holzinger G, Notohamiprodjo G, Betker S, Montanus H, Lehmann J, Gleichmann U. Relationship between LDL-cholesterol, coronary resistance and flow reserve. Eur J Nucl Med 1997;8:883.
64. Knuuti J, Harkonen R, Pitkanen O, Nuutila P, Raitakari O, Laine H, Takala T, Lida H, Viikari J, Ronnemaa T. Coronary flow reserve is reduced in young adult type 1 diabetic patients. Eur J Nucl Med 1997;8:883.
65. Bader JB, Hellwig D, Muller M, Stoll H, heisel A, Ozbek C, Scheiffer H, Kirsch C. Cardiac imaging of perfusion and sympathetic innervation by 123I MIBG/99mTcMlBI SPECT in patients scheduled for implantation of an intra cardiac defibrillator. Eur J Nucl Med 1997;8:998.
66. Lerch H, Schafers M, Wichter T, Rhodes C, Lammertsma A, Hermansen F, Schober O, Breithart G, Camici P. Global reduction of cardiac beta-receptor density in arrhythmogenic right ventricular cardiomyopathy. Eur J Nucl Med 1997;8: 863.
67. Prassopoulos V, Lekakis J, Nanas J, Alexopoulos G, Margari Z, Rapti A, Kostamis P, Stamatelopoulos S, Moulopoulos S. Cardiac I123 metaiodobenzylguanidine uptake in predicting early and late mortality in congestive heart failure. Eur J Nucl Med 1997;8:998.
68. Unlu M, Inanir S, Kitapçi MT, Cengel A, Yalcin R, Dortlemez H. Indium-111 antimyosin antibody uptake determines L-carnitine induced protective effects on active myocyte damage in advanced stage dilated cardiomyopathy. Eur J Nucl Med 1997;8:937.
69. Richter W, Aurisch R, Kettner S, Fischer S, Munz DL. Kinetics of Tc-99m Q12 (furifosmin) in patients submitted for routine myocardial SPECT. Eur J Nucl Med 1997;8:905.
70. Müller-Suur R, Strandberg E, Mesko L. Adenosin is superior to exercise for stress sestamibi tomography in CAD patients treated with beta blockers: a quantitative SPECT analysis. Eur J Nucl Med 1997;8:906.
71. Fikrle A, Lïscher D, Fleisch M, Lourens S, Haldeman A, Kinser J, Sulzer M, Mering W. Comparison of left ventricular ejection fraction assessed by gated Tc99m-MIBI SPECT after exercise and after dypiridamole. Eur J Nucl Med 1997;8:970.
72. Vanoli G, Rossetti C, Carpinelli A, Savi A, D'Angelo A, Crippa L, Deutsch E, Knight H, Lucignani G, Fazio F. Fresh thrombus imaging in humans with a new Tc99m-labeled peptidomimetic. Eur J Nucl Med 1997;8:946.
73. Paganelli G, Grana C, Chinol M, Cremonesi M, DeCicco C, De Braud F, Maggiolo M, Siccardi A. Antibody guided three step radiotherapy with Y90 biotin in glioma patients. Eur J Nucl Med 1997;8:908.
74. Han SH, Zonnenberg BA, Quirijnen JM, de Klerk J, van het Schip A, van Dijk A, van Rijk P. Efficacy of rhenium-186-etidronate in breast cancer patients with metastatic bone pain. Eur J Nucl Med 1997;8:895.
75. Gianmmarile F, Chauvot P, Desizinges C. Bone pain palliation with strontium-85 therapy: first evaluation in 59 patients. Eur J Nucl Med 1997;8:962.
76. Bestagno M, Palumbo R, Marinelli A, Paoletti F, Pedroli G, Puppo P, Reitano A, Viaggi S, Piffanelli A. Treatment with bone seeking radiopharmaceuticals of painful bone metastasis from prostate cancer: an experience of 500 patients of an Italian multicenter register. Eur J Nucl Med 1997;8:961.
77. Pinkert J, Franke WG, Hanig V, Neumann U, Hliscs R, Oehme L, Kühne A. Enhanced tumor uptake in I131-MIBG treatment by intraarterial application. Eur J Nucl Med 1997;8:908.
78. Riva P, Arista A, Franceschi G, Riva N, Casi M, Cremonini A, Guiducci G, Moscatelli G, Macke H. Feasibility and effectiveness of loco-regional radioimmunotherapy with I131 and Y90 labelled antitenascin MABs. Eur J Nucl Med 1997;8:939.
79. Behr TM, Memtsoudis S, Blumenthal RD, Dunn R, Sharkey R, Goldenberg D, Becker W. Complete versus fragmented. 131I versus 90Y labeled, antibodies for radioimmunotherapy of CEA expressing cancers: influence of the dose rate and renal accretion on toxicity and anti-tumor efficacy. Eur J Nucl Med 1997;8:868.
80. Perkins AC, Hughes ODM, Frier M, Bishop MC, Price NR, Denton G, Wastie M, Rutherford R, Schubiger P. Intravesical administration of Cu-67-595 MAb: a potential therapeutic conjugate for superficial bladder cancer. Eur J Nucl Med 1997;8:909.
81. Boerman OC, Oyen WJ, Storm L, Corvo L, Corstens F. Liposomes labeled with Tc99m to image experimental arthritis. Eur J Nucl Med 1997;8:933.
82. Van der Laan L, Oyen W, Verhofstad E, Tan E, Kapitein P, Hendriks T, Corstens F, Goris R. Tc99m-HYNIC-IgG for evaluation of soft tissue damage caused by oxygen derived free radicals. Eur J Nucl Med 1997;8:998.
83. Iturralde MP, Donough M. Tc99m-HMPAO labelled leucocytes in the diagnosis of chronic sinonasal inflammatory disease. Eur J Nucl Med 1997;8:887.
84. Malamitsi J, Christacopoulos J, Dounis E, Giamerellou E, Proukakis Ch. 99mTc-Ciprofloxacin (Infecton) as a means to detect bone and joint infection. Eur J Nucl Med 1997;8:876.
85. Gugiatti A, Rossetti C, Lucigniani G, Grimaldi A, Landoni C, Borgonovi E, Fazio F. Cost-effectiveness of different imaging techniques for the assessment of myocardial viability in Italy. Eur J Nucl Med 1997;8:939.
86. Giubbini R, Terzi A, Rossini P. Cost-effectiveness of Tc99m-sestamibi SPFCT in the detection of restenosis after PTCA. Eur J Nucl Med 1997;8:940.
87. Underwood R, Godman B, Salyani S, Ogle J, Ell P. Economics of myocardial perfusion imaging in Europe: The EMPIRE study. Eur J Nucl Med 1997;8:940.